K930185

Substantially Equivalent

OVUSIGN LH/CONCEPTION PLUS/OVUDATE LH ONE-STEP

Applicant: Princeton Biomedix
Product code: CEP
Advisory panel: Clinical Chemistry
Date received: 1993-01-14
Decision date: 1993-03-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Princeton, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.